Potential for false-positive results with quantitative antigen tests for SARS-CoV-2: A case of a child with acute respiratory infection.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 09 10 2021
revised: 22 10 2021
accepted: 30 10 2021
pubmed: 20 11 2021
medline: 19 1 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

The quantitative antigen test based on the chemiluminescent enzyme immunoassay for SARS-CoV-2 has been used in international airports for quarantine in Japan. While cases of false-positive rapid antigen tests for SARS-CoV-2 were reported, false-positive cases of the quantitative antigen test with clinical information are rare. Here, we report a case of acute respiratory infection whose quantitative antigen test for SARS-CoV-2 was suspected to be false positive. A 9-month-old boy who presented with fever and rhinorrhea was admitted to our hospital under the Quarantine Act. He was diagnosed with COVID-19 based on the quantitative antigen test for SARS-CoV-2 performed at the quarantine station. None of the accompanying family members were positive for COVID-19. Nucleic acid amplification tests (NAAT) for SARS-CoV-2 were all negative, and multiplex polymerase chain reaction detected human rhinovirus or enterovirus infection. This case suggests that the results of the quantitative antigen test should be interpreted together with clinical information, and NAAT should be performed when false-positive results are suspected to avoid unnecessary isolation.

Identifiants

pubmed: 34794870
pii: S1341-321X(21)00308-1
doi: 10.1016/j.jiac.2021.10.032
pmc: PMC8585597
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-320

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Ryota Hase (R)

Department of Infectious Diseases, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan; Department of Infectious Diseases, Kameda Medical Center, Kamogawa, Chiba, Japan, 929 Higashi-cho, Kamogawa, Chiba, 296-8602, Japan. Electronic address: hase.ryota@kameda.jp.

Takashi Kurita (T)

Department of Infectious Diseases, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan.

Haruki Mito (H)

Department of Infectious Diseases, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan.

Yudai Yano (Y)

Department of Infectious Diseases, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan.

Tomohisa Watari (T)

Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Chiba, Japan, 929 Higashi-cho, Kamogawa, Chiba, 296-8602, Japan.

Yoshihito Otsuka (Y)

Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Chiba, Japan, 929 Higashi-cho, Kamogawa, Chiba, 296-8602, Japan.

Nozomu Oshima (N)

Department of Pediatrics, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan.

Yasushi Noguchi (Y)

Department of Pediatrics, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, Narita, Chiba, 286-8523, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH